Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.

Two distinct isoforms of the human progesterone receptor (hPR-A and hPR-B) have been identified previously. They differ only in that hPR-B contains an additional 164 amino acids at the amino terminus. Among various species these two forms arise as a result of either alternate initiation of translation from the same mRNA or by transcription from alternate promoters within the same gene. In order to understand the reason for their existence, we studied the transcriptional capacity of these individual receptors and observed that their activity was influenced strongly by cell and promoter context. More surprising was the observation that in promoter and cell contexts where hPR-A was inactive, it acted as a potent trans-dominant repressor of hPR-B-mediated transcription. This event occurred at substoichiometric concentrations of hPR-A and was hormone dependent. Human PR-A was not a general repressor of ligand-mediated transcription, as it had no effect on vitamin D receptor function. Interestingly, hPR-A but not hPR-B was capable of a similar inhibition of glucocorticoid, androgen, and mineralocorticoid receptor-mediated gene transcription. This suggests a specific role for the hPR-A isoform in this regulatory process. The trans-dominant effects of hPR-A were induced also by the antiprogestins ZK112993 and ZK98299 and a DNA binding defective hPR-A mutant, suggesting that the inhibitory function of hPR-A does not require DNA binding. The dual role of hPR-A as an activator or repressor of transcription defines a potential mechanism by which cells can generate dissimilar responses to a single hormone and provides a molecular explanation for the existence of two distinct forms of the hPR.

[1]  C. Glass,et al.  The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements , 1988, Cell.

[2]  K. Umesono,et al.  Retinoic acid and thyroid hormone induce gene expression through a common responsive element , 1988, Nature.

[3]  K. Horwitz,et al.  Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Spelsberg,et al.  Seasonal changes in the molecular species and nuclear binding of the chick oviduct progesterone receptor. , 1979, Biochemistry.

[5]  D. Housman,et al.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. , 1987, Science.

[6]  B. O’Malley,et al.  Identification of a negative regulatory function for steroid receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Chambon,et al.  The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. , 1989, Nucleic acids research.

[8]  G. Schütz,et al.  A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Cooney,et al.  Chicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone, and retinoic acid receptors , 1992, Molecular and cellular biology.

[10]  H. Ponta,et al.  DNA sequences outside the receptor‐binding sites differently modulate the responsiveness of the mouse mammary tumour virus promoter to various steroid hormones. , 1988, The EMBO journal.

[11]  P. Chambon,et al.  Steroid hormone receptors compete for factors that mediate their enhancer function , 1989, Cell.

[12]  H. Gronemeyer,et al.  A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. , 1992, The Journal of biological chemistry.

[13]  Z. Parandoosh,et al.  Interaction of glucocorticoid analogues with the human glucocorticoid receptor , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  K. Umesono,et al.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.

[15]  M. Rosenfeld,et al.  Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain , 1988, Cell.

[16]  R. Evans,et al.  Functional domains of the human glucocorticoid receptor , 1986, Cell.

[17]  K. Horwitz,et al.  The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? , 1992, Endocrine reviews.

[18]  M. Privalsky,et al.  v-erbA acts on retinoic acid receptors in immature avian erythroid cells , 1993, Journal of virology.

[19]  B. O’Malley The steroid receptor superfamily: more excitement predicted for the future. , 1990, Molecular endocrinology.

[20]  T. Spelsberg,et al.  Nonfunctioning progesterone receptors in the developed oviducts from estrogen-withdrawn immature chicks and in aged nonlaying hens. , 1982, Endocrinology.

[21]  P. Chambon,et al.  Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. , 1990, The EMBO journal.

[22]  P. Chambon,et al.  The N-terminal region of the chicken progesterone receptor specifies target gene activation , 1988, Nature.

[23]  C. Clarke,et al.  Progestin regulation of cellular proliferation. , 1990, Endocrine reviews.

[24]  K. Calame,et al.  A dominant negative form of transcription activator mTFE3 created by differential splicing. , 1991, Science.

[25]  G. Ryffel,et al.  Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. , 1991, Nucleic acids research.